Search

Author/Creator Derman, Benjamin A

1. A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma. (15th February 2023)

Authors:
Derman, Benjamin A; Chari, Ajai; Zonder, Jeffrey; Major, Ajay; Stefka, Andrew T; Jiang, Ken; Karrison, Theodore; Jasielec, Jagoda; Jakubowiak, Andrzej
Journal:
European journal of haematology
Issue:
Volume 110:Number 5(2023)
Page Start:
564
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies. Issue 6 (22nd June 2022)

Authors:
Rouhani, Sherin Juliet; Yu, Jovian; Olson, Daniel; Zha, Yuanyuan; Pezeshk, Apameh; Cabanov, Alexandra; Pyzer, Athalia R; Trujillo, Jonathan; Derman, Benjamin A; O'Donnell, Peter; Jakubowiak, Andrzej; Kindler, Hedy L; Bestvina, Christine; Gajewski, Thomas F
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial. Issue 2 (February 2023)

Authors:
Dytfeld, Dominik; Wróbel, Tomasz; Jamroziak, Krzysztof; Kubicki, Tadeusz; Robak, Paweł; Walter-Croneck, Adam; Czyż, Jarosław; Tyczyńska, Agata; Druzd-Sitek, Agnieszka; Giannopoulos, Krzysztof; Nowicki, Adam; Szczepaniak, Tomasz; Łojko-Dankowska, Anna; Matuszak, Magdalena; Gil, Lidia; Puła, Bartos...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 2(2023)
Page Start:
139
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗